Annotated Medicine and Device Lists


Dabigatran

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 10.2. Medicines affecting coagulation This medicine has the best evidence for effectiveness and safety.
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anticoagulants Oral No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 01.03 ANTI-COAGULANT AND ANTIPLATELET DRUGS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 10. HEMATOLOGIA No observations
Barbados. Barbados National Drug Formulary (BNDF) 20.12.04.12. Direct Thrombin Inhibitors No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 10.2. Medicines affecting coagulation This medicine has the best evidence for effectiveness and safety.
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anticoagulants Oral No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 01.03 ANTI-COAGULANT AND ANTIPLATELET DRUGS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 10. HEMATOLOGIA No observations
Barbados. Barbados National Drug Formulary (BNDF) 20.12.04.12. Direct Thrombin Inhibitors No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 01.03 ANTI-COAGULANT AND ANTIPLATELET DRUGS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 10. HEMATOLOGIA Others observations:
etexilato
Barbados. Barbados National Drug Formulary (BNDF) 20.12.04.12. Direct Thrombin Inhibitors No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations

Information Resources: Dabigatran

Loading ...
Loading ...
Loading ...
No information available